Epigenic Therapeutics
Business Services · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4-15f6f Shanghai Free Trade Zone No. 1 L...Website
www.epigenictx.comRevenue
$10.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Epigenic Therapeutics
Epigenetic Therapeutics is a frontier biotechnology company dedicated to developing next-generation gene editing therapy utilizing the regulation of epigenetic genomes for a variety of diseases. Founded in 2021 by leading scientists focused on discovering gene editing technologies and developing gene editing therapies, the company has multiple product candidates in the pipeline, including treatment for ocular, neurodegeneration, metabolic, and rare diseases.Explore more
Epigenic Therapeutics Org Chart
YX
Head of Operations
QW
BD Head
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epigenic Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Epigenic Therapeutics is spiking on competitors!
Click to see if Epigenic Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Epigenic Therapeutics launches new products
Epigenic Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Epigenic Therapeutics
Earning: See what the market has to say on Epigenic Therapeutics recently announced quarterly report
Check if Epigenic Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Epigenic Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Epigenic Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
Epigenic Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Epigenic Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Epigenic Therapeutics.
Epigenic Therapeutics financials insights
Gather financial insights about Epigenic Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$20M
2023
Series A
$32M
2025
Series B
$60M
Epigenic Therapeutics Tech Stack
A closer look at the technologies used by Epigenic Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Epigenic Therapeutics News & Media
Epigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Medicines
SHANGHAI, Sept. 8, 2025 /PRNewswire/ -- Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of financing led by Lapam Capital, with continued participation from existing investors Qiming Venture Partners and OrbiMed, and addition of new investors including IFSC and a renowned investment firm in the industry. This round of funding will primarily support the ongoing clinical development of EPI-003Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B
SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, today announced that it has received approval of clinical trial application (CTA) from the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) and The Health and Disability Ethics Committees (HDEC) to initiate a clinical trial for EPI-003, which is an investigational, liver-targeting antiviral therapy for chronic hepatitiEpigenic joins wave of startups raising cash to edit the epigenome | BioPharma Dive
The China-based company is one of at least four young biotechs in a competitive race to use CRISPR tools to alter gene expression without changing DNA.Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development
SHANGHAI, Aug. 29, 2023 /PRNewswire/ -- Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome regulation to treat prevalent diseases, today announced that it has raised $32 million in Series A round of...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Epigenic Therapeutics
Sign Up For FreeTo access detailed company insights
Epigenetic Therapeutics is a frontier biotechnology company dedicated to developing next-generation gene editing therapy utilizing the regulation of epigenetic genomes for a variety of diseases. Founded in 2021 by leading scientists focused on discovering gene editing technologies and developing gene editing therapies, the company has multiple prod... Read More
